CDC recommends second COVID-19 bivalent booster for older adults, immunocompromised 

Apr 20, 2023 - 01:44 PM
Black person receiving vaccination in arm

The Centers for Disease Control and Prevention April 19 recommended a second Moderna or Pfizer COVID-19 bivalent vaccine dose for adults aged 65 and older at least four months after their initial bivalent dose, and for immunocompromised individuals at least two months after their initial bivalent dose, as authorized by the Food and Drug Administration. Immunocompromised individuals also may receive additional bivalent vaccine doses at the discretion of their health care provider. In addition, CDC continues to recommend a single Moderna or Pfizer COVID-19 bivalent vaccine dose for all Americans aged 6 and older. 

The FDA no longer authorizes the monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines for use in the United States. CDC’s recommendations for use of the monovalent Novavax and Johnson & Johnson COVID-19 vaccines remain unchanged.

CDC and its Advisory Committee on Immunization Practices “will continue to monitor COVID-19 disease levels and vaccine effectiveness in the months ahead and look forward to additional discussion around potential updates this fall,” CDC said.

Related News Articles

Headline
HHS reminds insurers to cover updated COVID-19 vaccines without cost sharing
Most health insurers must cover the updated COVID-19 vaccines from Pfizer and Moderna without cost sharing effective Sept. 11, when the Food and Drug…
Headline
AHA participates in CDC Fall Immunization Kick-off; COVID-19 vaccines for uninsured still free
AHA today participated in a Centers for Disease Control and Prevention Fall Immunization Kick-off Event for partner organizations, which focused on vaccinating…
Headline
FDA advisor declares ineffectiveness of widely used over-the-counter decongestant active ingredient
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
CDC recommends updated Moderna, Pfizer COVID-19 vaccines
As authorized yesterday by the Food and Drug Administration and recommended by its vaccine advisory committee, the Centers for Disease Control and Prevention…
Headline
HHS highlights price cap in contract to develop COVID-19 monoclonal antibody
Under the Department of Health and Human Services’ recent agreement with Regeneron to develop a new monoclonal antibody to prevent COVID-19, the U.S. list…
Headline
Infographic: Strategies for clearing up COVID-19 vaccine confusion 
In time for back-to-school health screenings, AHA Aug. 25 released an infographic on strategies that clinicians and the Centers for Disease Control and…